Ziwei Du

1.0k total citations
35 papers, 732 citations indexed

About

Ziwei Du is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Ziwei Du has authored 35 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Ziwei Du's work include Glioma Diagnosis and Treatment (10 papers), MicroRNA in disease regulation (7 papers) and Cancer Cells and Metastasis (6 papers). Ziwei Du is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), MicroRNA in disease regulation (7 papers) and Cancer Cells and Metastasis (6 papers). Ziwei Du collaborates with scholars based in China, United Kingdom and United States. Ziwei Du's co-authors include Youxin Zhou, Ting Sun, Yulun Huang, Xuetao Li, Yanyan Li, Xueshun Xie, Yunlun Li, Ke Pei, Tingfeng Wu and Yanqiang Jin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, The Journal of Organic Chemistry and Frontiers in Immunology.

In The Last Decade

Ziwei Du

34 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziwei Du China 14 377 227 120 92 85 35 732
Yan Cai China 18 469 1.2× 188 0.8× 58 0.5× 44 0.5× 126 1.5× 39 833
Junjeong Choi South Korea 11 450 1.2× 225 1.0× 84 0.7× 79 0.9× 255 3.0× 16 914
Dongming Yan China 17 390 1.0× 273 1.2× 69 0.6× 79 0.9× 85 1.0× 64 782
Pierangela Totta Italy 20 486 1.3× 122 0.5× 49 0.4× 112 1.2× 134 1.6× 27 1000
Lucia D’Antona Italy 17 436 1.2× 139 0.6× 80 0.7× 48 0.5× 108 1.3× 30 748
Jingzang Tao United States 5 545 1.4× 80 0.4× 84 0.7× 43 0.5× 74 0.9× 7 970
Mika Hori Japan 20 360 1.0× 239 1.1× 185 1.5× 32 0.3× 221 2.6× 70 1.1k
Fabien Forcheron France 14 231 0.6× 63 0.3× 112 0.9× 146 1.6× 58 0.7× 20 649
Rosanna C. Mirabile United States 13 580 1.5× 148 0.7× 111 0.9× 25 0.3× 69 0.8× 20 1.1k
Zeqi Zheng China 17 381 1.0× 158 0.7× 89 0.7× 20 0.2× 67 0.8× 48 786

Countries citing papers authored by Ziwei Du

Since Specialization
Citations

This map shows the geographic impact of Ziwei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziwei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziwei Du more than expected).

Fields of papers citing papers by Ziwei Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziwei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziwei Du. The network helps show where Ziwei Du may publish in the future.

Co-authorship network of co-authors of Ziwei Du

This figure shows the co-authorship network connecting the top 25 collaborators of Ziwei Du. A scholar is included among the top collaborators of Ziwei Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziwei Du. Ziwei Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yan, et al.. (2025). The Double-Edge Sword of Natural Phenanthrenes in the Landscape of Tumorigenesis. Molecules. 30(6). 1204–1204. 2 indexed citations
2.
An, Peng, Qian Wang, Na Huang, et al.. (2024). Cholic acid activation of GPBAR1 does not induce or exacerbate acute pancreatitis but promotes exocrine pancreatic secretion. Biochemical and Biophysical Research Communications. 735. 150825–150825. 1 indexed citations
3.
Li, Xin, et al.. (2024). Advances in the study of tertiary lymphoid structures in the immunotherapy of breast cancer. Frontiers in Oncology. 14. 1382701–1382701. 7 indexed citations
4.
Santerre, J. Paul, et al.. (2024). Biomaterials’ enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment. Frontiers in Immunology. 15. 1492323–1492323. 4 indexed citations
5.
Xu, Mengwei, Baocheng Xie, Qing Min, et al.. (2023). Insights on Antitumor Activity and Mechanism of Natural Benzophenanthridine Alkaloids. Molecules. 28(18). 6588–6588. 14 indexed citations
6.
Yuan, Yang, Ziwei Du, Wei Li, et al.. (2022). Novel clusters of newly-diagnosed type 2 diabetes and their association with diabetic retinopathy: a 3-year follow-up study. Acta Diabetologica. 59(6). 827–835. 6 indexed citations
7.
Liu, Jiang, et al.. (2022). The Prevalence and Risk Factors of Diabetic Retinopathy: Screening and Prophylaxis Project in 6 Provinces of China. Diabetes Metabolic Syndrome and Obesity. Volume 15. 2911–2925. 7 indexed citations
9.
Pei, Ke, Ting Gui, Yanqiang Jin, et al.. (2020). An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease. BioMed Research International. 2020(1). 4020249–4020249. 131 indexed citations
10.
Yang, Ying, Ke Pei, Qian Zhang, et al.. (2020). Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP/TAZ/JNK signaling pathway in endothelial cells and pericytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(10). 158779–158779. 50 indexed citations
11.
Li, Xuetao, Zhennan Tao, Hao Wang, et al.. (2020). Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs). Experimental Cell Research. 396(1). 112261–112261. 10 indexed citations
12.
Li, Ji‐Cheng, Yong Han, Dai Zhou, et al.. (2017). Downregulation of Survivin Gene Expression Affects Ionizing Radiation Resistance of Human T98 Glioma Cells. Cellular and Molecular Neurobiology. 38(4). 861–868. 8 indexed citations
13.
Wu, Haibin, Yanyan Li, Liang Shen, et al.. (2017). SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway. Journal of Neuro-Oncology. 135(2). 263–272. 35 indexed citations
14.
Han, Yong, Liang Zhou, Tingfeng Wu, et al.. (2015). Downregulation of lncRNA-MALAT1 Affects Proliferation and the Expression of Stemness Markers in Glioma Stem Cell Line SHG139S. Cellular and Molecular Neurobiology. 36(7). 1097–1107. 75 indexed citations
15.
Shen, Liang, Yanyan Li, Xuetao Li, et al.. (2015). MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway. Tumor Biology. 36(9). 6929–6938. 47 indexed citations
16.
Zhao, Zhaohui, Xingming Zhong, Tianquan Yang, et al.. (2014). Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme. International Journal of Molecular Medicine. 34(5). 1233–1240. 12 indexed citations
17.
Zhou, Youxin, Xionghui Chen, Xueshun Xie, et al.. (2012). Orthotopic model of SHG‐44 in the enhanced green fluorescent protein nude mouse. Journal of Neuroscience Research. 90(9). 1814–1819. 2 indexed citations
18.
Sun, Ting, Youxin Zhou, Xueshun Xie, et al.. (2012). Selective uptake of boronophenylalanine by glioma stem/progenitor cells. Applied Radiation and Isotopes. 70(8). 1512–1518. 12 indexed citations
19.
Zhou, Youxin, et al.. (2011). Analysis of Isocitrate Dehydrogenase 1 Mutation in 97 Patients with Glioma. Journal of Molecular Neuroscience. 47(3). 442–447. 9 indexed citations
20.
Zhou, Youxin, Yulun Huang, Ting Sun, et al.. (2011). The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251. Journal of Experimental & Clinical Cancer Research. 30(1). 114–114. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026